The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.
Open accessAbstract
IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through condomless sex with suppressed HIV-1 RNA viral load for both anal and vaginal sex. OBJECTIVE: To evaluate the rate of within-couple HIV transmission (heterosexual and men who have sex with men [MSM]) during periods of sex without condoms and when the HIV-positive partner had HIV-1 RNA load less than 200 copies/mL. DESIGN, SETTING, AND PARTICIPANTS: The prospective, observational PARTNER (Partners of People on ART-A New Evaluation of the Risks) study was conducted at 75 clinical sites in 14 European countries and enrolled 1166 HIV serodifferent couples (HIV-positive partner taking suppressive ART) who reported condomless sex (September 2010 to May 2014). Eligibility criteria for inclusion of couple-years of follow-up were condomless sex and HIV-1 RNA load less than 200 copies/mL. Anonymized phylogenetic analysis compared couples' HIV-1 polymerase and envelope sequences if an HIV-negative partner became infected to determine phylogenetically linked transmissions. EXPOSURES: Condomless sexual activity with an HIV-positive partner taking virally suppressive ART. MAIN OUTCOMES AND MEASURES: Risk of within-couple HIV transmission to the HIV-negative partner. RESULTS: Among 1166 enrolled couples, 888 (mean age, 42 years [IQR, 35-48]; 548 heterosexual [61.7%] and 340 MSM [38.3%]) provided 1238 eligible couple-years of follow-up (median follow-up, 1.3 years [IQR, 0.8-2.0]). At baseline, couples reported condomless sex for a median of 2 years (IQR, 0.5-6.3). Condomless sex with other partners was reported by 108 HIV-negative MSM (33%) and 21 heterosexuals (4%). During follow-up, couples reported condomless sex a median of 37 times per year (IQR, 15-71), with MSM couples reporting approximately 22,000 condomless sex acts and heterosexuals approximately 36,000. Although 11 HIV-negative partners became HIV-positive (10 MSM; 1 heterosexual; 8 reported condomless sex with other partners), no phylogenetically linked transmissions occurred over eligible couple-years of follow-up, giving a rate of within-couple HIV transmission of zero, with an upper 95% confidence limit of 0.30/100 couple-years of follow-up. The upper 95% confidence limit for condomless anal sex was 0.71 per 100 couple-years of follow-up. CONCLUSIONS AND RELEVANCE: Among serodifferent heterosexual and MSM couples in which the HIV-positive partner was using suppressive ART and who reported condomless sex, during median follow-up of 1.3 years per couple, there were no documented cases of within-couple HIV transmission (upper 95% confidence limit, 0.30/100 couple-years of follow-up). Additional longer-term follow-up is necessary to provide more precise estimates of risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additional studies of HIV mixed-status couples, heterosexual and MSM couples (PARTNER study), and MSM couples (Opposites Attract and PARTNERS2 studies) reported that patients with HIV taking ART who maintain an undetectable viral load demonstrate no risk for transmitting HIV to their HIV-negative sex partners (95–97).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Effective ART that suppresses HIV replication to undetectable levels reduces morbidity, provides a near-normal lifespan, and prevents sexual transmission of HIV to others (95–97,410–412).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persons with HIV infection who achieve and maintain a viral load suppressed to <200 copies/mL with ART have effectively no risk for sexually transmitting HIV (95–97,421).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [95]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N. K., Serwadda, D., Li, C., Wabwire‐Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 2,990
Attia, S. L., Egger, M., Müller, M. C. M., Zwahlen, M., & Low, N. N. (2009) · AIDS · doi:10.1097/qad.0b013e32832b7dca · Cited by 1,001
Donnell, D. J., Baeten, J. M., Kiarie, J. N., Thomas, K. K., Stevens, W. S., Cohen, C. R., McIntyre, J. A., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 970
Condom effectiveness in reducing heterosexual HIV transmission.
Weller, S. C., & Davis-Beaty, K. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003255 · Cited by 846
Baggaley, R. F., White, R. G., & Boily, M. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq057 · Cited by 713
Per-Contact Risk of Human Immunodificiency Virus Tramnsmision between Male Sexual Partners
Vittinghoff, E., Douglas, J., Judon, F., McKiman, D., MacQueen, K. M., & Buchinder, S. P. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010003 · Cited by 593
Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV
Castilla, J., del Romero, J., Hernando, V., Marincovich, B., García, S., & Rodríguez, C. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000157389.78374.45 · Cited by 383
Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART
Jin, F., Jansson, J., Law, M. G., Prestage, G., Zablotska, I., Imrie, J. C., Kippax, S. C., Kaldor, J. M., Grulich, A. E., & Wilson, D. P. (2010) · AIDS · doi:10.1097/qad.0b013e3283372d90 · Cited by 259
Reynolds, S. J., Makumbi, F. E., Nakigozi, G. F., Kagaayi, J., Gray, R. H., Wawer, M. J., Quinn, T. C., & Serwadda, D. (2010) · AIDS · doi:10.1097/qad.0b013e3283437c2b · Cited by 189
Flagged first, then by citations
Research works printed but not linked: 3
- [1]1. had no role in design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. PARTNER Study Group: Spain: Hospital Virgen del Rocío, Sevilla: V. Pompeyo, M. Trastoy, R. Palacio. Hospital General de Elche: F. Gutiérrez, M. Masiá, S. Padilla, C. Robledano. Hospital Universitari Germans Trias i Pujol, Badalona: B. Clotet, P. Coll. Hospital La Paz, Madrid: J. Peña. Hospital Universitario San Carlos, Madrid: V. Estrada, M. Rodrigo, E. Santiago. Hospital Universitario Reina Sofia De Cordoba: A. Rivero. Hospital Clínico Universitario de Santiago de Compostela: A. Antela, E. Losada, C. Lires, A. Aguilera. Hospital Clínic de Barcelona, Barcelona: J. Gatell. Centro Sanitario Sandoval, Madrid: J. Guerrero. Hospital Ramon y Cajal, Madrid: F. Dronda. Hospital Carlos III, Madrid: V. Soriano. United Kingdom: Chelsea and Westminster Hospital, London: D. Asboe, N. Nwokolo, J. Sewell. Mortimer Market Clinic, London: R. Gilson, N. Esteban, S. McNamara. Royal Free Hospital: A. Rodger, K. Sturgeon. Southmead Hospital, Bristol: M. Gompels, L. Jennings. Coventry and Warwickshire Hospital: S. Allan. Edinburgh Infectious Diseases, University of Edinburgh: C. Leen, S. Morris. King's College Hospital: M. Brady, L. Campbell. Brighton: M. Fisher. Leicester Royal Infirmary: J. Dhar. Newham: R. O'Connell. Birmingham Heartlands: D. White. St Thomas Hospital, London: J. Fox. St Mary's Hospital, London: S. Fidler. Bradford: P. Stanley. Earnsdale, Redhill: U. Natarajan. Northampton: M. Ghanem. North Middlesex University Hospital, London: J. Ainsworth, A. Waters. North Manchester General Hospital: E. Wilkins. St James's, Leeds: J. Minton, J. Calderwood. Hastings: H. Patel. Whipps Cross Hospital, London: M. Lascar. Germany: University Clinic, Hamburg Eppendorf: J. Lunzen. University Hospital Cologne: T. Kümmerle, G. Fätkenheuer, E. Rund, C. Lehmann. Praxis Driesener Straße, Berlin: I.
- [5]5. Quinn TC, Wawer MD, Sewankambo N, et al; Rakai Project Study Group. Viral load and heterosexual transmission of HIV type 1. N Engl J Med. 2000;342:921-929.
- [25]25. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitment antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des médecins suisses 89 (5), 2008. English translation, including translator's affidavit. http://tinyurl.com/cpyt5N. Accessed December 31, 2015.
Cited by
Sorted by citations
Items 101–200 of 1,000
Roles for Pharmacists in the “Ending the HIV Epidemic: A Plan for America” Initiative
McCree, D. H., Byrd, K. K., Johnston, M., Gaines, M. T., & Weidle, P. J. (2020) · Public Health Reports · doi:10.1177/0033354920941184 · Cited by 51
Damulak, P. P., Ismail, S., Manaf, R. A., Said, S. M., & Agbaji, O. O. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052477 · Cited by 50
Treatment and prevention of HIV infection with long-acting antiretrovirals
Benítez‐Gutiérrez, L., Soriano, V., Requena, S., Arias, A., Barreiro, P., & de Mendoza, C. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1453805 · Cited by 50
The HIV Care Cascade Among Transgender Women with HIV in Canada: A Mixed-Methods Study
Lacombe‐Duncan, A., Bauer, G. R., Logie, C. H., Newman, P. A., Shokoohi, M., Kay, E. S., Persad, Y., O’Brien, N., Kaida, A., de Pokomandy, A., et al. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0013 · Cited by 53
Grace, D., Nath, R., Parry, R., Connell, J., Wong, J., & Grennan, T. (2020) · Culture Health & Sexuality · doi:10.1080/13691058.2020.1776397 · Cited by 50
Tavoschi, L., Vroling, H., Madeddu, G., Babudieri, S., Monarca, R., Noordegraaf‐Schouten, M. V., Beer, N., Dias, J. G., O’Moore, É., Hedrich, D., et al. (2018) · Epidemiologic Reviews · doi:10.1093/epirev/mxy001 · Cited by 50
HIV and Solid Organ Transplantation: Where Are we Now
Botha, J. F., Fabian, J., Etheredge, H. R., Conradie, F., & Tiemessen, C. T. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00460-7 · Cited by 49
Addressing Ethical Challenges in US-Based HIV Phylogenetic Research
Dawson, L., Benbow, N., Fletcher, F. E., Kassaye, S. G., Killelea, A., Latham, S. R., Lee, L. M., Leitner, T., Little, S. J., Mehta, S. R., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa107 · Cited by 49
Daskalopoulou, M., Rodger, A. J., Phillips, A. N., Sherr, L., Elford, J., McDonnell, J., Edwards, S., Perry, N., Wilkins, E., Collins, S., et al. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-053029 · Cited by 48
Self-citationParaskevis, D. N., Beloukas, A. I., Stasinos, K., Pantazis, N., de Mendoza, C., Bannert, N., Meyer, L., Zangerle, R., Gill, M. J., Prins, M., et al. (2019) · BMC Medicine · doi:10.1186/s12916-018-1241-1 · Cited by 48
Self-citationUK guideline for the use of HIV post‐exposure prophylaxis 2021
Cresswell, F. V., Asanati, K., Bhagani, S., Boffito, M., Delpech, V., Ellis, J. P., Fox, J., Furness, L., Kingston, M., Mansouri, M., et al. (2022) · HIV Medicine · doi:10.1111/hiv.13208 · Cited by 53
Self-citationStrömdahl, S. K., Höijer, J., & Eriksen, J. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2019-054007 · Cited by 45
No. 354-Canadian HIV Pregnancy Planning Guidelines
Loutfy, M. R., Kennedy, V. L., Poliquin, V., Dzineku, F., Dean, N. L., Margolese, S. L., Symington, A. L., Money, D., Hamilton, S., Conway, T., et al. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.06.033 · Cited by 45
Halperin, J., Butler, I., Conner, K., Myers, L., Holm, P., Bartram, L., & Sickels, N. J. V. (2018) · AIDS Patient Care and STDs · doi:10.1089/apc.2017.0309 · Cited by 45
Garín, N., Zurita, B., Velasco, C., Feliu, A., Gutiérrez, M. D. M., Masip, M., & Mangues, M. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014105 · Cited by 44
Chow, E. P. F., Walker, S. M., Hocking, J. S., Bradshaw, C. S., Chen, M. Y., Tabrizi, S. N., Howden, B. P., Law, M. G., Maddaford, K., Read, T. R. H., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2541-3 · Cited by 45
Housing First: Unsuppressed Viral Load Among Women Living with HIV in San Francisco
Riley, E. D., Vittinghoff, E., Koss, C. A., Christopoulos, K., Clemenzi-Allen, A., Dilworth, S. E., & Carrico, A. W. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02601-w · Cited by 44
Foster, C., Ayers, S., & Fidler, S. J. (2020) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120920177 · Cited by 44
Shahmanesh, M., Mthiyane, N., Herbst, C., Neuman, M., Adeagbo, O., Mee, P., Chimbindi, N., Smit, T. K., Okesola, N., Harling, G., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004574 · Cited by 44
Belief in Treatment as Prevention and Its Relationship to HIV Status and Behavioral Risk
Card, K. G., Armstrong, H. L., Lachowsky, N. J., Cui, Z., Sereda, P., Carter, A., Montaner, J. S. G., Hogg, R. S., Roth, E. A., & Moore, D. M. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001557 · Cited by 45
Temporal Trends in the Epidemiology of HIV in Turkey
Erdinç, F. Ş., Dokuzoğuz, B., Ünal, S., Kömür, S., İnkaya, A. Ç., İnan, D., Karaoğlan, İ., Deveci, A., Çelen, M. K., Köse, Ş., et al. (2020) · Current HIV Research · doi:10.2174/1570162x18666200427223823 · Cited by 42
The role of machine learning in HIV risk prediction
Fieggen, J., Smith, E., Arora, L., & Segal, B. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2022.1062387 · Cited by 45
90-90-90-Plus: Maintaining Adherence to Antiretroviral Therapies
Corless, I. B., Hoyt, A., Tyer‐Viola, L. A., Sefcik, E. F., Kemppainen, J. K., Holzemer, W. L., Eller, L. S., Nokes, K. M., Phillips, J. C., Dawson-Rose, C. S., et al. (2017) · AIDS Patient Care and STDs · doi:10.1089/apc.2017.0009 · Cited by 42
Li, J., Peng, L., Gilmour, S., Gu, J., Ruan, Y., Zou, H., Hao, C., Hao, Y., & Lau, J. T. F. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3516-8 · Cited by 42
Interaction of the Host and Viral Genome and Their Influence on HIV Disease
Tough, R. H., & McLaren, P. J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00720 · Cited by 43
Glynn, T. R., Llabre, M. M., Lee, J. S., Bedoya, C. A., Pinkston, M. M., O’Cleirigh, C. M., & Safren, S. A. (2019) · International Journal of Behavioral Medicine · doi:10.1007/s12529-019-09786-3 · Cited by 46
Prevention of HIV Transmission and the HPTN 052 Study
Cohen, M. S., Gamble, T., & McCauley, M. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-110918-034551 · Cited by 42
Diabetes mellitus in people living with HIV/AIDS: prevalence and associated risk factors
da Cunha, G. H., Franco, K. B., Galvão, M. T. G., Lima, M. A. C., Fontenele, M. S. M., Siqueira, L. R., Ramalho, A. K. L., & Fechine, F. V. (2019) · AIDS Care · doi:10.1080/09540121.2019.1695727 · Cited by 42
Prioritising pleasure and correcting misinformation in the era of U=U
Calabrese, S. K., Mayer, K. H., & Marcus, J. L. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(20)30341-6 · Cited by 42
Vega-Ramírez, H., Torres, T. S., Guillén-Díaz-Barriga, C., Pimenta, C., Díaz-Sosa, D. M., Konda, K. A., Caruso, A., Robles, R., Benedetti, M., Hoagland, B., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07900-y · Cited by 41
Self-citationOkafor, U., Crutzen, R., Aduak, Y., Adebajo, S. B., & van den Borne, H. W. (2017) · African Journal of AIDS Research · doi:10.2989/16085906.2017.1358753 · Cited by 41
Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis
Krebs, E., Enns, B., Wang, L., Zang, X., Panagiotoglou, D., del Rı́o, C., Dombrowski, J. C., Feaster, D. J., Golden, M. R., Granich, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217559 · Cited by 43
Quinn, K. G., Christenson, E. A., Sawkin, M. T., Hacker, E., & Walsh, J. L. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02747-7 · Cited by 41
Crepaz, N., Dong, X., Hess, K. L., & Bosh, K. A. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002277 · Cited by 41
Carneiro, P. B., Westmoreland, D. A., Patel, V. V., & Grov, C. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-02990-3 · Cited by 41
Rodrigues, A., Struchiner, C. J., Coelho, L. E., Veloso, V. G., Grinsztejn, B. G. J., & Luz, P. M. (2021) · BMC Public Health · doi:10.1186/s12889-021-10421-8 · Cited by 41
Lama, J. R., Brezak, A., Dobbins, J. G., Sánchez, H., Cabello, R. L., Ríos, J., Bain, C. E., Ulrich, A. K., Grecca, R. D. L., Sánchez, J., et al. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy030 · Cited by 40
Witzel, T. C., Weatherburn, P., Rodger, A. J., Bourne, A. H., & Burns, F. M. (2017) · BMC Public Health · doi:10.1186/s12889-017-4370-0 · Cited by 39
Self-citationCastro, R., Boni, R. B. D., Luz, P. M., Velasque, L. D. S., Lopes, L. P. D. C., Medina‐Lara, A., Cardoso, S. W., Oliveira, M. S. D., Friedman, R. K., Grinsztejn, B. G. J., et al. (2018) · Quality of Life Research · doi:10.1007/s11136-018-2044-8 · Cited by 39
Siegel, K., & Meunier, É. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02405-y · Cited by 39
Huang, Y., Sun, H., Chuang, Y., Huang, Y., Lin, K., Huang, S., Chen, G., Luo, Y.-Z., Wu, P., Liu, W., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-033246 · Cited by 39
Interventions to improve the HIV continuum of care in China
Zhang, X., Wang, N., Vermund, S. H., Zou, H., Li, X., Zhang, F., & Qian, H. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00469-y · Cited by 39
Sexual transmission of infections across Europe: appraising the present, scoping the future
Geretti, A. M., Mårdh, O., de Vries, H. J. C., Winter, A., McSorley, J., Seguy, N., Vuylsteke, B., & Gökengin, D. (2022) · Sexually Transmitted Infections · doi:10.1136/sextrans-2022-055455 · Cited by 39
Self-citationBrown, M. J., Harrison, S. E., & Li, X. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02440-9 · Cited by 38
Longitudinal Effects of Syndemics on HIV-Positive Sexual Minority Men’s Sexual Health Behaviors
Harkness, A., Bainter, S. A., O’Cleirigh, C. M., Albright, C. A., Mayer, K. H., & Safren, S. A. (2019) · Archives of Sexual Behavior · doi:10.1007/s10508-018-1329-x · Cited by 39
HIV Prevention and Treatment: The Evolving Role of the Emergency Department
Stanley, K. A., Lora, M. H., Merjavy, S., Chang, J. J., Arora, S., Menchine, M. D., & Jacobson, K. R. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.01.018 · Cited by 37
Carter, A., de Pokomandy, A., Loutfy, M. R., Ding, E., Sereda, P., Webster, K., Nicholson, V., Beaver, K., Hogg, R. S., & Kaida, A. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2453-8 · Cited by 36
Piña, C., Dange, A., Rawat, S. M., Jadhav, U., Arnsten, J. H., Chhabra, R., & Patel, V. V. (2017) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2017.10.001 · Cited by 36
Lucar, J. A., Hart, R. L. D., Rayeed, N., Terzian, A. S., Weintrob, A., Siegel, M., Parenti, D. M., Squires, L. E., Williams, R. C., Castel, A. D., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy017 · Cited by 36
Successful treatment of HIV eliminates sexual transmission
Cohen, M. S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30701-9 · Cited by 36
Feinstein, B. A., & Dodge, B. (2019) · Archives of Sexual Behavior · doi:10.1007/s10508-019-01468-1 · Cited by 36
Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine
Hammoud, M., Jin, F., Maher, L., Bourne, A. H., Haire, B. G., Saxton, P. J. W., Vaccher, S. J., Lea, T., Degenhardt, L. J., & Prestage, G. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02739-7 · Cited by 36
HIV/AIDS Comorbidities: Impact on Cancer, Noncommunicable Diseases, and Reproductive Health
Casper, C., Crane, H. M., Menon, M. P., & Money, D. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0524-0_ch3 · Cited by 38
Contemporary protease inhibitors and cardiovascular risk
Lundgren, J. D., Mocroft, A., & Ryom, L. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000425 · Cited by 35
Self-citationMolina, J., Grund, B., Gordin, F. M., Williams, I. G., Schechter, M., Losso, M. H., Law, M. G., Ekong, E., Mwelase, N., Skoutelis, A. T., et al. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30003-1 · Cited by 36
Self-citationCarey, J. W., Carnes, N., Schoua‐Glusberg, A., Kenward, K., Gelaude, D., Denson, D. J., Gall, E. M., Randall, L. A., & Frew, P. M. (2018) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0018 · Cited by 35
HIV, HCV and HBV: A Review of Parallels and Differences
Leoni, M. C., Ustianowski, A., Farooq, H. Z., & Arends, J. E. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0210-5 · Cited by 35
Too many people with viral hepatitis are diagnosed late — with dire consequences
Lazarus, J. V., Picchio, C. A., Dillon, J. F., Rockstroh, J. K., Weis, N. M., & Buti, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0177-z · Cited by 35
Huntingdon, B., Muscat, D. M., de Wit, J. B. F., Duracinský, M., & Juraskova, I. (2019) · The Journal of Sex Research · doi:10.1080/00224499.2019.1689379 · Cited by 35
Lacombe‐Duncan, A., Logie, C. H., Persad, Y., Leblanc, G., Nation, K., Kia, H., Scheim, A. I., Lyons, T., Horemans, C., Olawale, R., et al. (2021) · BMC Medical Education · doi:10.1186/s12909-021-02991-3 · Cited by 40
Hirshfield, S., Teran, R. A., Downing, M. J., Chiasson, M. A., Tieu, H., Dize, L., & Gaydos, C. A. (2018) · JMIR Public Health and Surveillance · doi:10.2196/10847 · Cited by 35
Low Level Viremia Among People Living with HIV-1 in Nigeria
Chun, H., Abutu, A. A., Milligan, K., Ehoche, A., Shiraishi, R. W., Odafe, S. F., Dalhatu, I., Onotu, D., Okoye, M. I. J., Oladipo, A., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00413-2 · Cited by 34
Purcell, D. W., Higa, D. H., Mizuno, Y., & Lyles, C. M. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1800-z · Cited by 34
Maragh‐Bass, A. C., Gamble, T., El‐Sadr, W., Hanscom, B. S., & Tolley, E. E. (2020) · Journal of Behavioral Medicine · doi:10.1007/s10865-020-00186-7 · Cited by 33
Tanner, M. R., O’Shea, J., Byrd, K. M., Johnston, M., Dumitru, G. G., Le, J. N., Lale, A., Byrd, K. K., Cholli, P. A., Kamitani, E., et al. (2025) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7401a1 · Cited by 33
Gilbert, H. N., Wyatt, M. A., Pisarski, E. E., Muwonge, T. R., Heffron, R. A., Katabira, E. T., Celum, C., Baeten, J. M., Haberer, J. E., & Ware, N. C. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002139 · Cited by 33
Viral Rebound Among Persons With Diagnosed HIV Who Achieved Viral Suppression, United States
Craw, J. A., Beer, L., Tie, Y., Jaenicke, T., Shouse, R. L., & Prejean, J. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002321 · Cited by 33
Mind the Gap: HIV Prevention Among Young Black Men Who Have Sex with Men
Fields, E. L., Hussen, S. A., & Malebranche, D. J. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00532-z · Cited by 33
Luz, P. M., Torres, T. S., Almeida-Brasil, C. C., Marins, L. M. S., Veloso, V. G., Grinsztejn, B. G. J., Cox, J., & Moodie, E. E. M. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-03035-5 · Cited by 33
Lacombe‐Duncan, A., Kia, H., Logie, C. H., Todd, K. P., Persad, Y., Leblanc, G., Nation, K., Scheim, A. I., Lyons, T., Horemans, C., et al. (2020) · Health & Social Care in the Community · doi:10.1111/hsc.13234 · Cited by 38
Holt, M., Draper, B. L., Pedrana, A. E., Wilkinson, A. L., & Stoove, M. A. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2097-2 · Cited by 33
Aoko, A., Pals, S. L., Ngugi, T., Katiku, E., Joseph, R., Basiye, F. L., Kimanga, D. O., Kimani, M., Masamaro, K., Ngugi, E. W., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102166 · Cited by 32
Calabrese, S. K., Kalwicz, D. A., Zaheer, M. A., Dovidio, J. F., Garner, A., Zea, M. C., Treloar, C., Holt, M., Smith, A. K. J., MacGibbon, J., et al. (2024) · AIDS and Behavior · doi:10.1007/s10461-023-04263-1 · Cited by 32
Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital
Todd, S., Rafferty, P., Walker, E., Hunter, M., Dinsmore, W., Donnelly, C., McCarty, E., Quah, S. P., & Emerson, C. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462416688127 · Cited by 32
Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018
Davies, N., Ashford, G., Bekker, L., Chandiwana, N. C., Cooper, D. D., Dyer, S., Jankelowitz, L., Mhlongo, O., Mnyani, C. N., Mulaudzi, M. B., et al. (2018) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v19i1.915 · Cited by 33
Scott, H. M., Vittinghoff, E., Irvin, R., Liu, A., Nelson, L. E., del Rı́o, C., Magnus, M., Mannheimer, S., Fields, S. D., Tieu, H., et al. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02616-3 · Cited by 32
Redefining therapeutic success in HIV patients: an expert view
Antela, A., Rivero, A., Llibre, J. M., Moreno, S., the RET Group, Antela, A., Llibre, J. M., Moreno, S., Rivero, A., Montero, M., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab168 · Cited by 32
Self-citationVirologic outcomes in early antiretroviral treatment: HPTN 052
Eshleman, S. H., Wilson, E., Zhang, X. C., Ou, S., Piwowar‐Manning, E., Eron, J. J., McCauley, M., Gamble, T., Gallant, J. E., Hosseinipour, M. C., et al. (2017) · HIV Clinical Trials · doi:10.1080/15284336.2017.1311056 · Cited by 32
Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
Zilber, E., Martin, G. E., Willberg, C. B., Fox, J., Nwokolo, N. C., Fidler, S. J., & Frater, J. (2019) · AIDS · doi:10.1097/qad.0000000000002165 · Cited by 32
White, J. J., Dangerfield, D. T., & Grieb, S. M. D. (2019) · Public Health Nursing · doi:10.1111/phn.12592 · Cited by 32
Data-Driven Goals for Curbing the U.S. HIV Epidemic by 2030
Bradley, H. M., Rosenberg, E. S., & Holtgräve, D. R. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02442-7 · Cited by 32
New initiatives to develop self-testing for HIV
Witzel, T. C., & Rodger, A. J. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000336 · Cited by 31
Self-citationMatthews, L. T., Burns, B., Bajunirwe, F., Kabakyenga, J. K., Bwana, M., Ng, C., Kastner, J., Kembabazi, A., Sanyu, N., Kusasira, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183131 · Cited by 31
Mayer, K. H., Maloney, K. M., Levine, K., King, D. S., Grasso, C., Krakower, D., Rosenberg, E. S., & Boswell, S. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx214 · Cited by 32
the SUPA Group, Glendinning, E., Spiers, J., Smith, J. A., Anderson, J., Campbell, L. J., Cooper, V., & Horne, R. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02670-x · Cited by 31
Wells, N., Philpot, S. P., Murphy, D., Ellard, J., Howard, C., Rule, J., Fairley, C. K., Prestage, G., RISE Study Team, Brown, G., et al. (2022) · Health & Social Care in the Community · doi:10.1111/hsc.13886 · Cited by 31
Payne, C., Houle, B. C., Chinogurei, C., Riumalló‐Herl, C., Kabudula, C. W., Kobayashi, L. C., Salomon, J. A., & Manne‐Goehler, J. (2022) · The Lancet HIV · doi:10.1016/s2352-3018(22)00198-9 · Cited by 31
Individualized antiretroviral therapeutic approaches
Katlama, C., Ghosn, J., & Murphy, R. L. (2017) · AIDS · doi:10.1097/qad.0000000000001476 · Cited by 31
Parry, S., Bundle, N., Ullah, S., Foster, G. R., Ahmad, K., Tong, C. Y. W., Balasegaram, S., & Orkin, C. M. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818000870 · Cited by 31
Gray, R. T., Wilson, D. P., Guy, R., Stoove, M. A., Hellard, M. E., Prestage, G., Lea, T., de Wit, J. B. F., & Holt, M. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25104 · Cited by 30
For the Opposites Attract study group, Philpot, S. P., Prestage, G., Ellard, J., Grulich, A. E., & Bavinton, B. R. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2247-6 · Cited by 30
Self-citationHightow‐Weidman, L., Magnus, M., Beauchamp, G. G., Hurt, C. B., SHOPTAW, S. J., Emel, L., Piwowar‐Manning, E., Mayer, K. H., Nelson, L. E., Wilton, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1141 · Cited by 30
Gómez‐Ayerbe, C., Martínez‐Sanz, J., Muriel, A., Elías, P. P., Moreno, A., Barea, R., Polo, L., Cano, A., Uranga, A., Santos, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220375 · Cited by 30
Challenges of reaching 90–90–90 in the Southern United States
Colasanti, J. A., & Armstrong, W. S. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000577 · Cited by 30
Chimbindi, N., Mthiyane, N., Zuma, T., Baisley, K. J., Pillay, D., McGrath, N. M., Harling, G., Sherr, L., Birdthistle, I. J., Floyd, S., et al. (2021) · AIDS Care · doi:10.1080/09540121.2021.1902933 · Cited by 30
Accuracy of self‐report of HIV viral load among people with HIV on antiretroviral treatment
Sewell, J., Daskalopoulou, M., Nakagawa, F., Lampe, F. C., Edwards, S., Perry, N., Wilkins, E., O'Connell, R., Jones, M., Collins, S., et al. (2016) · HIV Medicine · doi:10.1111/hiv.12477 · Cited by 30
Self-citationEnding the Human Immunodeficiency Virus Pandemic: Optimizing the Prevention and Treatment Toolkits
Eisinger, R. W., Folkers, G. K., & Fauci, A. S. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz998 · Cited by 30
van Griensven, F., Guadamuz, T. E., van Wijngaarden, J. W. D. L., Phanuphak, N., Solomon, S. S., & Lo, Y.-R. J. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052669 · Cited by 29
Predictors of adherence to antiretroviral therapy among PLHIV
Paramesha, A., & Chacko, L. K. (2019) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_376_18 · Cited by 29
Undetectable Equals Untransmittable: A Game Changer for HIV Prevention
Patel, R. R., Curoe, K. A., & Chan, P. A. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz010 · Cited by 29
Metadata
- Authors
- Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., Asboe, D., Viciana, P., Gutiérrez, F., Clotet, B., Pradier, C., Gerstoft, J., Weber, R., Westling, K., Wandeler, G., Prins, J. M., Rieger, A., Stoeckle, M., Kümmerle, T., Bini, T., Ammassari, A., Gilson, R., Krznaric, I., Ristola, M., Zangerle, R., Handberg, P., Antela, A., Allan, S., Phillips, A. N., Lundgren, J., & for the PARTNER Study Group
- Affiliations
- University College London (GB)
- University of Copenhagen (DK)
- Kantonsspital St. Gallen (CH)
- HIV i-Base, London, United Kingdom
- University Medical Center Hamburg-Eppendorf, Hamburg-Eppendorf, Germany
- European AIDS Treatment Group, Bruxelles, Belgium
- Universidad Complutense de Madrid (ES)
- Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
- University of Liverpool (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- Hospital Universitario Virgen del Rocío (ES)
- Universitat de Miguel Hernández d'Elx (ES)
- Universitat Autònoma de Barcelona (ES)
- Laboratoire Motricité Humaine Éducation Sport Santé (FR)
- Rigshospitalet (DK)
- University of Zurich (CH)
- Karolinska University Hospital (SE)
- University of Bern (CH)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medical University of Vienna (AT)
- University Hospital of Basel (CH)
- University Hospital Cologne (DE)
- Ospedale San Paolo (IT)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
- Praxis Driesener Straße, Berlin, Germany
- Helsinki University Hospital (FI)
- Innsbruck Medical University (AT)
- Hvidovre Hospital (DK)
- Complejo Hospitalario Universitario de Santiago (ES)
- Coventry and Warwickshire Hospital, Coventry, United Kingdom
- ORCID
- Rodger, Alison J.
- Cambiano, Valentina
- Vernazza, Pietro
- Collins, Simon
- Corbelli, Giulio Maria
- Estrada, Vicente
- Beloukas, Apostolos
- Asboe, David
- Gutiérrez, Félix
- Clotet, Bonaventura
- Pradier, Christian
- Gerstoft, Jan
- Weber, Rainer
- Westling, Katarina
- Wandeler, Gilles
- Prins, Jan M.
- Rieger, Armin
- Stoeckle, Marcel
- Ammassari, Adriana
- Gilson, Richard
- Krznaric, Ivanka
- Ristola, Matti
- Zangerle, Robert
- Antela, Antonio
- Allan, Sris
- Phillips, Andrew N.
- Lundgren, Jens
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-07-12
- Volume
- 316
- Issue
- 2
- Pages
- 171
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2461009619
- Cited by
- 1,431
- References
- 21
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 112 · 2023: 139 · 2022: 146 · 2021: 164 · 2020: 169 · 2019: 226 · 2018: 166 · 2017: 141 · 2016: 24
- FWCI
- 171.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Scopus (Elsevier) (submittedVersion, other-oa)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Institute for Health and Care Research (PB-PG-1013-32069, RP-PG-0608-10142)
- National Research Foundation
- Danmarks Grundforskningsfond
- Programme Grants for Applied Research (RP-PG-0608-10142)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- unprotected sex, HIV-1 RNA suppression, antiretroviral therapy, men who have sex with men, heterosexual couples, HIV prevention, phylogenetic analysis, viral load, anal sex, vaginal intercourse, HIV-negative men who have sex with men, HIV-negative women, HIV-negative children
- MeSH terms
- Adult, Europe, Family Characteristics, Female, HIV Seropositivity, Humans, Male, Middle Aged, Phylogeny, Prospective Studies, Risk, RNA, Viral, Sexual Behavior, Sexual Partners, HIV-1, HIV Infections, Condoms, HIV Seronegativity, Anti-HIV Agents, Viral Load, Unsafe Sex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review